Rising prevalence of cancer, growing standardization of pathological laboratories, technological advancements in diagnostic and molecular techniques for etiology and cytology procedures, and favorable reimbursements for cancer screening and laboratory tests are major factors contributing to high CAGR of Etiology and Cytology market during the forecast period.
According to the recent etiology of Reports and Data, the global etiology and cytology market was valued at USD 12.61 Billion in 2019 and is expected to reach USD 34.51 Billion by the year 2027, exhibiting a CAGR of 13.2%. Etiology and Cytology procedures are related to the diagnosis of diseases and other conditions. Etiology is the study of human tissues, which includes structure and function, whereas cytology is the study of human cells. Etiology and cytology market had experienced a huge growth with regards to healthcare industries as several fatal diseases can be diagnosed through these clinical studies.
Currently, use of molecular techniques is a widely accepted method in etiology and cytology as an enabler of morphology for diagnosing and prognosing. Moreover, the study of markers of therapeutic response has been helpful in some types of neoplasms for diagnosing cancer. There are numerous advantages in the use of cytological material to perform molecular studies: ease of obtaining fresh sample, ability to check the quality of the sample immediately after draw and better preservation of DNA and RNA. The possibility of using genomic and proteomic research in small quantities of sample obtained by fine-needle aspiration (ENA) can minimize invasive procedures and allow the monitoring of cancer, thereby increasing the demand of etiology and cytology procedures. PCR, microarrays, proteomic and other sequencing methodologies are now being validated in cytological samples. Proper specimen processing is of utmost importance in maintaining morphology and nucleic acid integrity. The role of the cytopathologist is mandatory in the collection and selection of cells. Histopathology evaluation basically compares diseased or experimentally altered tissues with matching sample from healthy or control counterparts. Therefore, it is very important to rigor-ously standardize every etiology process (i.e., specimen sam-pling, trimming, embedding, sectioning, and staining). Cytology allows the identification of malignancy from a small quantity of cells. Cervical Pap smears are the most widely accepted example of this kind of testing and have dramatically reduced the incidence of cervical carcinoma. Cytology provides patients a minimally or non-invasive means of obtaining samples and allows etiology of samples such as exfoliated cells in sputum and urine, and pleural, pericardial, cyst fluids. Fine needle aspiration provides cell samples from small lesions, and under image guidance from inaccessible sites such as the lung, head of pancreas and para-aortic lymph nodes. Specimens are often very small and to obtain maximum utility, the process should be performed by trained technicians and using proper and high-end cytology and etiology equipment. Growing awareness about the screening of cancer and technological advancements in the cell and tissue studies are likely to boost the demand during the forecast period. An increasing number of well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to propel market growth. Advancements in cytology and etiology save time for pathologists, making the service more cost-effective. Low cost, high sensitivity, and adequate specificity associated with cytology examination procedure will further bolster the etiology and cytology market growth. Efficient testing of samples can result in cost-saving and faster outcomes to patients and increasing awareness of individuals about their health. Stringent regulation is one of the key factors for hampering the growth of etiology and cytology market.
Key companies profiled in the report include
Abbott Laboratories; Becton Dickinson and Company; BrandTech Scientific, Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; Southwest Precision Instruments, and Trivitron Healthcare
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2194
The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Etiology and Cytology market.
The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive etiology of the competitive landscape. It provides an industry-wide etiology of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.
The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.
The key geographical regions analyzed in the market report are:
- North America (U.S.A., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Etiology and Cytology Market Segmentation based on Types:
Type of Examination in Etiology and Cytology market (Revenue, USD Million; 2017–2027)
- Cytology
- Cervical Cancer
- Breast Cancer
- Other Cancers
- Etiology
Test Type in Etiology and Cytology market (Revenue, USD Million; 2017–2027)
- Microscopy methods
- Cytochemistry and histochemistry
- Immunohistochemistry and Immunofluorescence
- Flow cytometry
- Molecular genetic methods
- Cytogenic tests
- karyotyping
- fluorescent in situ hybridization (FISH)
- Polymerase chain reaction
- Others
End-use of Etiology and Cytology market (Revenue, USD Million; 2017–2027)
- Hospitals/Clinics
- Biopharmaceuticals companies
- Academia
- Other end-users
Order this Report @ https://www.reportsanddata.com/report-pricing/2194
Further key findings from the report suggest
- Etiology and cytology market had experienced a huge growth in the healthcare industry as several fatal diseases can be diagnosed through these clinical studies
- Roche launched the VENTANA DP 200 slide scanner which is a high-speed slide scanner for digital pathology in March 2019. It reduces workflow errors and improves image quality. Such product launches are expected to drive etiology and cytology market
- Cytology testing attributed to large disease prevalence and adoption of the test for cervix screening. The segment can maintain its leading position during the forecast period due to the recent entry of various tests and advantages over etiology such as faster etiology and cost-effectiveness
- Flow Cytometry sub-segment was expected to show the maximum CAGR during the forecast period within the test type segmentation of the etiology and cytology. This segment is used to detect and measure characteristics of cell mainly used in laboratories which contribute to the market growth of this product segment
- The etiology and cytology market will prove advantageous to the Asia-Pacific region to a great extent. It’s CAGR was the highest amongst all regions during the forecast period.The major factor driving the growth of this market is the huge population density in countries like India and China and increasing awareness about these tests
- In September 2019, Phillips launched computational pathology software, Tissue Mark, for automated ovarian and prostate tumor detection, which provides doctors and lab technicians with an effective etiology and cytology diagnosis tool
Request For customization @ https://www.reportsanddata.com/request-customization-form/2194
Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.
Browse More Reports:
Vacutainer Market @ https://www.biospace.com/article/vacutainer-market-size-share-top-key-players-growth-trend-and-forecast-till-2028/
Thawing System Market @ https://www.biospace.com/article/thawing-system-market-size-share-growth-etiology-trend-and-forecast-research-report-by-2028/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
